Previous close | 213.60 |
Open | 214.40 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 214.40 - 214.50 |
52-week range | 149.40 - 217.30 |
Volume | |
Avg. volume | 3 |
Market cap | 61.4B |
Beta (5Y monthly) | 1.09 |
PE ratio (TTM) | 43.33 |
EPS (TTM) | 4.95 |
Earnings date | 30 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | 2.13 (0.99%) |
Ex-dividend date | 18 Jun 2024 |
1y target est | N/A |
Veeva (VEEV) announces the availability of Vault Basics for biotechs, which aims to deliver complete and pre-validated solutions for expanding businesses.
AxoGen (AXGN) starts the process of BLA submission to the FDA for the approval of its Avance Nerve Graft.
BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.